Bodycote stock advances during takeover offer period as shares gain over 30 percent in 2026

Bodycote plc (GB00B3FLWH99) stock is trading higher in 2026, with the shares up more than 30 percent since the start of the year as the company remains in a formal takeover offer period as of August 17, 2026.

The UK Takeover Panel has listed Bodycote as an offeree company with CVC Advisers Limited identified as a potential offeror, and set a Rule 2.6 deadline of 5:00 p.m. on September 2, 2026 for a possible bid to be announced or withdrawn, according to the Disclosure Table updated on August 17, 2026. The Takeover Panel Disclosure Table shows that the offer period for Bodycote commenced at 4:12 p.m. on August 5, 2026.

Market data from a share price overview indicates that Bodycote stock was trading at GBX 698 on January 1, 2026 and has increased by 31.3 percent to trade around GBX 916.50 as of August 17, 2026, highlighting a strong year-to-date performance for the shares. A detailed market overview also shows a recent quote near GBX 913.50 with a small daily change and a first-January change of more than 30 percent, indicating that the stock is trading within a relatively narrow daily range while maintaining substantial gains for 2026.

Takeover panel sets early September deadline

The takeover situation around Bodycote has crystallized in August 2026 as the UK Takeover Panel formally placed the company in an offer period and identified CVC Advisers Limited as a potential bidder, creating a clear timeline for strategic decisions.

According to the Disclosure Table update dated August 17, 2026, Bodycote is recorded as an offeree with its ordinary shares, ISIN GB00B3FLWH99, and 170,187,993 securities in issue under the offer period entry. The disclosure entry notes that the offer period for Bodycote commenced at 4:12 p.m. on August 5, 2026 and that CVC Advisers Limited was identified as the offeror at the same time, providing clarity on both the start of the process and the interested party.

Crucially for investors, the same table sets a Rule 2.6 deadline of 5:00 p.m. on September 2, 2026, by which CVC must either announce a firm intention to make an offer for Bodycote or confirm that it does not intend to make an offer, unless the Panel agrees to an extension. The Rule 2.6 timetable is a key structural feature of UK takeover rules, and in this case it gives market participants a clearly defined event date at the start of September that could materially affect Bodycote stock's valuation depending on whether a formal bid emerges.

The disclosure also lists Bodycote's legal entity identifier, confirming the company’s identity within the Panel's framework, and places it alongside various other offeree companies in ongoing UK offer periods. This context underscores that Bodycote is now part of a broader wave of corporate activity monitored by the Panel, where potential acquirers are working against specific deadlines.

Share price performance and year-to-date gains

While the takeover process sets the strategic backdrop, Bodycote stock's trading performance in 2026 provides an important numerical reference point for investors evaluating the situation.

Market data as of August 17, 2026 shows that Bodycote's share price has risen from GBX 698 at the opening of January 1, 2026 to around GBX 916.50, representing a gain of 31.3 percent over this period. The share price overview highlights that this year-to-date rise has taken the stock close to the upper end of its recent trading range, and a parallel quote of GBX 913.50 displayed for real-time trading on August 17, 2026 shows only a 0.08 percent daily change, indicating relatively stable intraday action compared with the larger trend move.

The same pricing snapshot notes that the first-January change for Bodycote stands above 30 percent, a figure that aligns with the increase from GBX 698 to the mid-900s in GBX terms. A real-time quote summary lists GBX 913.50 with a modest negative five-day change and a first-January percentage gain of around 30.49 percent, reinforcing the message that the shares have delivered notable performance over the year even if the latest short-term movements are small.

For investors assessing potential takeover scenarios, this combination of a substantial year-to-date rise and a relatively calm daily price pattern can matter. A strong advance from January suggests that the market has already repriced Bodycote in light of both its fundamental profile and corporate interest, while the narrow daily movement on August 17, 2026 indicates that traders are waiting for more concrete takeover developments rather than reacting aggressively to minor news flow.

Bodycote's market performance also positions it favorably within mid-cap UK industrial names that benefit when acquirers see value in specialized engineering capabilities. With the shares holding in the GBX 900 region, any potential offer price from CVC or another party would be evaluated against this existing market level and the year-to-date gains already achieved, making the relationship between the current quote and any rumoured premium a central comparison point.

Consensus expectations and valuation context

Beyond the takeover narrative and price action, consensus data on Bodycote offers an additional lens for understanding how analysts view the company’s earnings and revenue outlook.

A consensus and revisions snapshot lists a real-time quote of GBX 913.50 for Bodycote on August 17, 2026, along with metrics such as a small five-day percentage change and a first-January gain above 30 percent, combining market pricing with analyst expectations. The consensus overview aligns the quotation with changes in earnings forecasts and revenue expectations, although the detailed table values for EPS and revenue projections are not fully visible in the immediate snapshot.

Even without every individual forecast line, the presence of an updated consensus page keyed to the August 17, 2026 trading session suggests that analysts are actively refreshing their models in light of the takeover offer period and the stock's 2026 gains. From a valuation standpoint, a 31.3 percent year-to-date share price increase prompts a quantitative question: whether current forecast earnings and cash flows justify the new market level, or whether a bid premium would be required to incentivize shareholders to accept an offer.

If a future detailed consensus data set were consulted, typical metrics would include forward price-to-earnings ratios, enterprise-value-to-EBITDA multiples, and revenue growth estimates. While the exact figures are not directly exposed in the snippet, the positioning of Bodycote within an active consensus revisions framework means that professional coverage continues to monitor both the takeover dynamics and the underlying industrial performance, providing a structured backdrop against which potential acquirers such as CVC might assess valuation.

The interaction between consensus expectations and takeover pricing is especially important in UK mid-cap deals, where bidders often need to justify a premium over both the undisturbed share price and the forward earnings outlook. In Bodycote’s case, a year-to-date gain of more than 30 percent moves the undisturbed baseline higher, so any bid might be evaluated against a stock that has already re-rated rather than one trading at depressed levels, thereby influencing negotiations and shareholder decisions.

Bodycote’s heat treatment and thermal processing services

Bodycote plc operates as a specialist provider of heat treatment, thermal processing, and related metallurgical services that enhance the performance, durability, and safety of components used across industries such as automotive, aerospace, energy, and general engineering.

In practice, the company’s service portfolio includes processes such as carburizing, nitriding, vacuum heat treatment, and surface technologies that modify the microstructure of metals to improve attributes like hardness, fatigue resistance, and corrosion protection. These services are typically carried out for customers who design and manufacture parts requiring precise mechanical properties, ranging from gears and engine components to structural elements in aircraft and performance-critical hardware in energy infrastructure.

Bodycote’s business model is built around a network of specialist facilities equipped with furnaces and thermal processing equipment, allowing it to offer standardized quality and certification while tailoring individual treatments to specific customer specifications. The company benefits from long-term industrial trends that favor outsourcing of complex heat treatment to dedicated providers, as manufacturers seek consistency, cost efficiency, and compliance with standards without maintaining all processes in-house.

In the context of the current takeover offer period, this industrial footprint and expertise in thermal processing represent the operational foundation that potential bidders like CVC would be evaluating. The attractiveness of Bodycote’s services stems from their role in critical supply chains: high-performance metal components often cannot meet required standards without specialized heat treatment, making Bodycote’s capabilities integral to many customers’ product performance and safety.

Shares trade in London with strong 2026 performance

Bodycote stock trades on the London Stock Exchange under the ticker BOY, and the shares’ strong 2026 performance provides a numerical anchor for investors considering both standalone and takeover scenarios.

As of August 17, 2026, market data shows the shares trading in the GBX 913.50 to 916.50 range, with the price up from GBX 698 on January 1, 2026, corresponding to a 31.3 percent year-to-date increase. The share price summary and associated charts indicate modest short-term fluctuations but a clear upward trajectory over the year.

While the exact intraday time stamp of the quote is not detailed in the snippet, the data is associated with real-time trade information on August 17, 2026, confirming that the GBX 913.50 level is reflective of the most recent trading session. For investors, the link between the current share price and the Rule 2.6 deadline on September 2, 2026 frames a near-term window in which both market sentiment and potential bid news could drive further changes in Bodycote’s valuation.

Fact box

Company: Bodycote plc
ISIN: GB00B3FLWH99
Ticker: BOY
Exchange: London Stock Exchange
Price (as of August 17, 2026, latest available trading data): GBX 916.50
Sector / Industry: Industrial services / thermal processing